Cryo-Cell International, Inc. Stock Other OTC
Equities
CCEL
US2288951088
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 31.78M | Sales 2025 * | 35.21M | Capitalization | 63.78M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 1M | EV / Sales 2024 * | 2.01 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.81 x |
P/E ratio 2024 * |
262
x | P/E ratio 2025 * |
65.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 97-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
Harold Berger
BRD | Director/Board Member | 60 | 11-08-24 |
1st Jan change | Capi. | |
---|---|---|
-14.17% | 85.42B | |
+17.86% | 84.38B | |
+10.92% | 29.39B | |
-8.51% | 17.49B | |
-2.67% | 16.44B | |
-0.24% | 15.28B | |
-3.63% | 11.71B | |
+2.63% | 12.22B | |
-30.53% | 11.98B |